Description: This report evaluates alternative payment models that potentially could be instituted by healthcare payers and manufacturers.

Description: A literature review was performed on mortality improvement, socioeconomic differences in mortality and their links to specific causes of death, and methods for analysis. It highlighted the fact that socioeconomic status (e.g., income and education) is closely linked to differences in mortality and that the longevity gap between socioeconomic groups is growing over time. It also informed the selection of key variables and the need to view mortality improvement as a complex interaction between specific causes of death.

Description: This report models and forecasts future mortality improvements in China, by geographical regions, as well as by causes of death. Deaths and population exposures data provided by the Chinese Center for Disease Control and Prevention was used for the period 2004–2019.

Description: COVID has washed over healthcare like a tsunami. According to Medicare actuaries, trends have been turned upside down in 2021, but will reverse back in 2023 as medical costs rebound. It is more prudent to base projections on long run trends for a period after the storm, extrapolating from 2026 forward, leaving the intervening turbulence (years 2022 -2025) mostly unspecified.

Description: This primer paper seeks to introduce and update the actuarial profession to the topic of insurance policies and genetics and study the impacts on insurance and potential responses.

Description: This report summarizes industry mortality experience for the period 2009 - 2016. This report is updated on a mostly annual basis and based on information aggregated from industry VM-51 submissions

Description: Guaranteed Issue mortality valuation tables, report, and definition.

Description: The Health Care Cost Trends Strategic Research Committee is looking for a research proposal that will examine the increased uptake of diabetes drugs on overall medical trends as well as the costs of individuals who are prescribed these drugs.

Description: The Reinsurance Section, Product Development Section and the Committee on Life Insurance Research are pleased to present results from a company practice survey of individual life insurance accelerated underwriting. Performed by a Milliman team led by Al Klein and Karen Rudolph, the study provides perspectives from both direct life insurance companies and reinsurers. Among the areas addressed include the structure of accelerated underwriting programs, how programs are monitored, how accelerated underwritten business is performing relative to expectations and how companies are considering accelerated underwriting cohorts in the context of VM-20 assumption setting.

Description: This paper provides actuaries with background and scientific knowledge to understand global climate change and climate model projections for the 21st century.